Redcare Pharmacy NV (SHPPF)
USD 135.79
(0.0%)
USD 135.79
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 244.83 Million EUR | -4.06% |
| 2022 | 255.19 Million EUR | 7.93% |
| 2021 | 236.43 Million EUR | 518.4% |
| 2020 | 38.23 Million EUR | -74.37% |
| 2019 | 149.2 Million EUR | 68.2% |
| 2018 | 88.7 Million EUR | 642.17% |
| 2017 | 11.95 Million EUR | 4123.32% |
| 2016 | 283 Thousand EUR | -98.51% |
| 2015 | 19 Million EUR | 0.0% |
| 2014 | - EUR | 0.0% |
| 2013 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 244.14 Million EUR | 0.28% |
| 2024 Q1 | 243.46 Million EUR | -0.56% |
| 2023 Q2 | 256.7 Million EUR | -0.22% |
| 2023 Q3 | 244.36 Million EUR | -4.81% |
| 2023 FY | 244.83 Million EUR | -4.06% |
| 2023 Q1 | 257.27 Million EUR | 0.82% |
| 2023 Q4 | 244.83 Million EUR | 0.19% |
| 2022 Q1 | 238.19 Million EUR | 0.74% |
| 2022 Q3 | 274.7 Million EUR | 2.39% |
| 2022 FY | 255.19 Million EUR | 7.93% |
| 2022 Q2 | 268.3 Million EUR | 12.64% |
| 2022 Q4 | 255.19 Million EUR | -7.1% |
| 2021 Q3 | 255.32 Million EUR | -0.12% |
| 2021 Q1 | 255.71 Million EUR | 568.84% |
| 2021 FY | 236.43 Million EUR | 518.4% |
| 2021 Q4 | 236.43 Million EUR | -7.4% |
| 2021 Q2 | 255.63 Million EUR | -0.03% |
| 2020 Q2 | 168.4 Million EUR | -5.17% |
| 2020 Q1 | 177.59 Million EUR | 19.03% |
| 2020 FY | 38.23 Million EUR | -74.37% |
| 2020 Q4 | 38.23 Million EUR | -77.54% |
| 2020 Q3 | 170.22 Million EUR | 1.08% |
| 2019 Q2 | 21.65 Million EUR | -75.26% |
| 2019 FY | 149.2 Million EUR | 68.2% |
| 2019 Q4 | 149.2 Million EUR | 539.28% |
| 2019 Q3 | 23.33 Million EUR | 7.79% |
| 2019 Q1 | 87.53 Million EUR | -1.32% |
| 2018 Q4 | 88.7 Million EUR | 1767.45% |
| 2018 FY | 88.7 Million EUR | 642.17% |
| 2018 Q1 | 4.22 Million EUR | -64.65% |
| 2018 Q2 | 4.76 Million EUR | 12.8% |
| 2018 Q3 | 4.75 Million EUR | -0.34% |
| 2017 Q3 | - EUR | 0.0% |
| 2017 FY | 11.95 Million EUR | 4123.32% |
| 2017 Q4 | 11.95 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 19.71 Million EUR | 0.0% |
| 2016 Q4 | 283 Thousand EUR | -98.59% |
| 2016 Q3 | 20.07 Million EUR | 1.81% |
| 2016 FY | 283 Thousand EUR | -98.51% |
| 2015 Q4 | 19 Million EUR | 0.0% |
| 2015 FY | 19 Million EUR | 0.0% |
| 2015 Q1 | - EUR | 0.0% |
| 2014 FY | - EUR | 0.0% |
| 2013 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | -58785.297% |
| Allstar Health Brands, Inc. | 2.21 Million USD | -10977.209% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 16.87 Million USD | -1350.804% |
| Café Serendipity Holdings, Inc. | 412.56 Thousand USD | -59245.171% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 272.02 Thousand USD | -89904.705% |
| HealthWarehouse.com, Inc. | 2.73 Million USD | -8835.964% |
| LIGAND PHARMACEUTICAL INC | 6.16 Million USD | -3871.419% |
| MedGen, Inc. | 24.47 USD | -1000563855.864% |
| Omni Health, Inc. | 1.84 Million USD | -13197.408% |
| Oxford Investments Holdings Inc. | 207.06 Thousand USD | -118142.098% |
| Pineapple, Inc. | 8.1 Million USD | -2919.15% |
| ScripsAmerica, Inc. | 1.2 Million USD | -20255.552% |